RT @CCalabreseDO: RA patients failing either UPA or adalimumab may benefit from switching to the other therapy abstr#2907 #ACR19 @RheumNow
Tweet Content
RA patients failing either UPA or adalimumab may benefit from switching to the other therapy abstr#2907 #ACR19 @RheumNow
Show on Archive Page
On
Display in Search Results
On